ATRX and neoplasm: It is of note, however, that the frequency of ATRX mutations identified in ALT tumours and cell lines appears markedly more prevalent than those identified for DAXX, with no DAXX mutations yet identified in oligodendriglomas, medulloblastomas and several ALT-immortalized cell lines6, 24.